Best Practices

Researchers to study whether plasma of recovered patients can treat COVID-19

Researchers from across Canada will collaborate on a vast clinical trial to study whether the plasma of recovered patients can be used to treat COVID-19.
Toronto researchers work on blood test to identify COVID-19 immunity
Chlorthalidone not preferred over hydrochlorothiazide for hypertension treatment

Study finds no difference in cardiovascular benefits, but greater risk of renal and electrolyte abnormalities with chlorthalidone
Finance: if you're diversified don't hit the panic button
Hydroxychloroquine for COVID-19 prevention or treatment lacks clinical evidence

Pharmacy and medical organizations issue statements to discourage off-label prescribing
Dire scenario for intensive care even if COVID-19 infection rate drops: study

That scenario assumes the average daily rate of infections over 37 days would be 7.5% compared with the 26% daily rate that Canada has experienced recently
Anterior hip replacement approach found to increase complications
Aerosol and fomite transmission SARS-CoV-2 is plausible

NEJM: presence in aerosol of SARS-CoV-2 similar to that of CoV-1

Pharmacologic treatments under study for COVID-19